Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 6

Results: 36

Diffuse alveolar hemorrhage: an evolving problem?

Published in:

2003

By:

Weisdorf, D J

Publication type:

journal article

Lack of telomerase activity in human mesenchymal stem cells.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1146, doi. 10.1038/sj.leu.2402962

By:

Zimmermann, S;
Voss, M;
Kaiser, S;
Kapp, U;
Waller, C F;
Martens, U M

Publication type:

Article

Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1200, doi. 10.1038/sj.leu.2402894

By:

Strupp, C;
Hildebrandt, B;
Germing, U;
Haas, R;
Gattermann, N

Publication type:

Article

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1013, doi. 10.1038/sj.leu.2402922

By:

van der Velden, V H J;
Hochhaus, A;
Cazzaniga, G;
Szczepanski, T;
Gabert, J;
van Dongen, J J M

Publication type:

Article

Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1104, doi. 10.1038/sj.leu.2402895

By:

Sanhes, L;
Tang, R;
Delmer, A;
DeCaprio, J A;
Ajchenbaum-Cymbalista, F

Publication type:

Article

A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection.

Published in:

2003

By:

Ballerini, P;
Blaise, A;
Mercher, T;
Pellegrino, B;
Perot, C;
van den Akker, J;
Gatbois, E;
Adam, M;
Douay, L;
Berger, R;
Bernard, O;
Landman-Parker, J

Publication type:

research

Functional characterization of human CD34+ cells that express low or high levels of the membrane antigen CD111 (nectin 1).

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1137, doi. 10.1038/sj.leu.2402916

By:

Belaaloui, G;
Imbert, A-M;
Bardin, F;
Tonnelle, C;
Dubreuil, P;
Lopez, M;
Chabannon, C

Publication type:

Article

High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1091, doi. 10.1038/sj.leu.2402918

By:

Ishizawa, S;
Slovak, M L;
Popplewell, L;
Bedell, V;
Wrede, J E;
Carter, N H;
Snyder, D S;
Arber, D A

Publication type:

Article

Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1112, doi. 10.1038/sj.leu.2402919

By:

Qiao, Y;
Ogawa, S;
Hangaishi, A;
Yuji, K;
Izutsu, K;
Kunisato, A;
Imai, Y;
Wang, L;
Hosoya, N;
Nannya, Y;
Sato, Y;
Maki, K;
Mitani, K;
Hirai, H

Publication type:

Article

Substance P - a potent risk factor in childhood lymphoblastic leukaemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1096, doi. 10.1038/sj.leu.2402920

By:

Nowicki, M;
Miskowiak, B

Publication type:

Article

PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).

Published in:

2003

By:

Strehl, S;
Konig, M;
Dworzak, M N;
Kalwak, K;
Haas, O A;
König, M

Publication type:

journal article

Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.

Published in:

2003

By:

Blalock, W L;
Navolanic, P M;
Steelman, L S;
Shelton, J G;
Moye, P W;
Lee, J T;
Franklin, R A;
Mirza, A;
McMahon, M;
White, M K;
McCubrey, J A

Publication type:

journal article

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1175, doi. 10.1038/sj.leu.2402924

By:

Nefedova, Y;
Landowski, T H;
Dalton, W S

Publication type:

Article

Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1192, doi. 10.1038/sj.leu.2402931

By:

Siraj, A K;
Kamat, S;
Gutierrez, M I;
Banavali, S;
Timpson, G;
Sazawal, S;
Bhargava, M;
Advani, S;
Adde, M;
Magrath, I;
Bhatia, K

Publication type:

Article

Treatment of elderly patients (=60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1085

By:

Mandelli, F;
Latagliata, R;
Avvisati, G;
Fazi, P;
Rodeghiero, F;
Leoni, F;
Gobbi, M;
Nobile, F;
Gallo, E;
Fanin, R;
Amadori, S;
Vignetti, M;
Fioritoni, G;
Ferrara, F;
Peta, A;
Giustolisi, R;
Broccia, G;
Petti, M C;
Lo-Coco, F

Publication type:

Article

Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1164, doi. 10.1038/sj.leu.2402936

By:

Mimori, K;
Kiyokawa, N;
Taguchi, T;
Suzuki, T;
Sekino, T;
Nakajima, H;
Saito, M;
Katagiri, Y U;
Isoyama, K;
Yamada, K;
Matsuo, Y;
Fujimoto, J

Publication type:

Article

Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1051

By:

Gonzalez, D;
Gonzalez, M;
Alonso, M E;
Lopez-Perez, R;
Balanzategui, A;
Chillon, M C;
Silva, M;
Garcia-Sanz, R;
San Miguel, J F

Publication type:

Article

Imatinib mesylate (GleevecTM) reduces phlebotomy requirements in polycythemia vera.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1186, doi. 10.1038/sj.leu.2402938

By:

Silver, R T

Publication type:

Article

Myelodysplasia - therapeutic response to novel therapy and the need for new diagnostic groups.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1183, doi. 10.1038/sj.leu.2402939

By:

Schiller, G J

Publication type:

Article

In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 999, doi. 10.1038/sj.leu.2402940

By:

Kindler, T;
Breitenbuecher, F;
Kasper, S;
Stevens, T;
Carius, B;
Gschaidmeier, H;
Huber, C;
Fischer, T

Publication type:

Article

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1068, doi. 10.1038/sj.leu.2402943

By:

Metelitsa, L S;
Weinberg, K I;
Emanuel, P D;
Seeger, R C

Publication type:

Article

Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1196, doi. 10.1038/sj.leu.2402944

By:

Payelle-Brogard, B;
Magnac, C;
Oppezzo, P;
Dumas, G;
Dighiero, G;
Vuillier, F

Publication type:

Article

Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1150, doi. 10.1038/sj.leu.2402946

By:

Schots, R;
Kaufman, L;
Van Riet, I;
Ben Othman, T;
De Waele, M;
Van Camp, B;
Demanet, C

Publication type:

Article

Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1157, doi. 10.1038/sj.leu.2402947

By:

Taghon, T;
Thys, K;
De Smedt, M;
Weerkamp, F;
Staal, F J T;
Plum, J;
Leclercq, G

Publication type:

Article

Stem cells and diversity.

Published in:

2003

By:

McCulloch, E A

Publication type:

journal article

Prevention and therapy of fungal infections in bone marrow transplantation.

Published in:

2003

By:

Baden, L R

Publication type:

journal article

Current CML therapy: progress and dilemma.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1010, doi. 10.1038/sj.leu.2402951

By:

Hehlmann, R

Publication type:

Article

Donor leukocyte infusions in acute myelogenous leukemia.

Published in:

2003

By:

Porter, D L

Publication type:

journal article

Retinoic acid and steroid in acute promyelocytic leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1203

By:

Hicsonmez, G

Publication type:

Article

Effect of NF-?B/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1190, doi. 10.1038/sj.leu.2402953

By:

Romano, M F;
Petrella, A;
Bisogni, R;
Turco, M C;
Venuta, S

Publication type:

Article

Questioning the aim of CML therapy in the era of Imatinib?

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1199, doi. 10.1038/sj.leu.2402954

By:

Carella, A M

Publication type:

Article

Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1078, doi. 10.1038/sj.leu.2402955

By:

He, X-Y;
Pohlman, B;
Lichtin, A;
Rybicki, L;
Kalaycio, M

Publication type:

Article

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1100, doi. 10.1038/sj.leu.2402958

By:

Tsimberidou, A-M;
Kantarjian, H M;
Estey, E;
Cortes, J E;
Verstovsek, S;
Faderl, S;
Thomas, D A;
Garcia-Manero, G;
Ferrajoli, A;
Manning, J T;
Keating, M J;
Albitar, M;
O'Brien, S;
Giles, F J

Publication type:

Article

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1130, doi. 10.1038/sj.leu.2402959

By:

Viehmann, S;
Teigler-Schlegel, A;
Bruch, J;
Langebrake, C;
Reinhardt, D;
Harbott, J

Publication type:

Article

Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1124, doi. 10.1038/sj.leu.2402963

By:

Primo, D;
Tabernero, M D;
Rasillo, A;
Sayagues, J M;
Espinosa, A B;
Chillon, M C;
Garcia-Sanz, R;
Gutierrez, N;
Giralt, M;
Hagemeijer, A;
San Miguel, J F;
Orfao, A

Publication type:

Article

Rare coincidence of hypertriploid chromosome number and aberrant coexpression of the lymphoid-associated antigen CD5 in acute myeloid Leukaemia FAB M0.

Published in:

Leukemia (08876924), 2003, v. 17, n. 6, p. 1188, doi. 10.1038/sj.leu.2402965

By:

Kahl, C;
Knopp, A;
Steiner, B;
Leithauser, M;
Wilhelm, S;
Kleine, H-D;
Wolff, D;
Casper, J;
Freund, M

Publication type:

Article

Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 6

Diffuse alveolar hemorrhage: an evolving problem?

Lack of telomerase activity in human mesenchymal stem cells.

Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome.

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.

A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection.

Functional characterization of human CD34<sup>+</sup> cells that express low or high levels of the membrane antigen CD111 (nectin 1).

High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.

Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.

Substance P - a potent risk factor in childhood lymphoblastic leukaemia.

PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).

Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.

Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West.

Treatment of elderly patients (=60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.

Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.

Imatinib mesylate (Gleevec<sup>TM</sup>) reduces phlebotomy requirements in polycythemia vera.

Myelodysplasia - therapeutic response to novel therapy and the need for new diagnostic groups.

In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.

Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation.

Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.

Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development.

Stem cells and diversity.

Prevention and therapy of fungal infections in bone marrow transplantation.

Current CML therapy: progress and dilemma.

Donor leukocyte infusions in acute myelogenous leukemia.

Retinoic acid and steroid in acute promyelocytic leukemia.

Effect of NF-?B/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34<sup>+</sup> cells.

Questioning the aim of CML therapy in the era of Imatinib?

Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.

Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL<sup>+</sup> leukemias: incidence and underlying genetic abnormalities.

Rare coincidence of hypertriploid chromosome number and aberrant coexpression of the lymphoid-associated antigen CD5 in acute myeloid Leukaemia FAB M0.